From the Formulator to the Tablet Manufacturing Floor: Desiderata and Troubleshooting

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-01-2001
Volume 2001 Supplement
Issue 4

Tablet manufacturers often overlook critical basic concepts or established practices. The author draws from his own experiences and discusses how solid dosage manufacturers can improve production and product quality by optimizing major unit operations.

Recent Videos
Drug Digest: Challenges and Triumphs in Next-Generation Biotherapeutic Development
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Related Content